Intellia Therapeutics NTLA Return on invested capital

Return on invested capital at other companies

Ionis PharmaceuticalsIONS

-80.3%+2,757pp

CRISPR TherapeuticsCRSP

-32.4%+6.6pp

Beam TherapeuticsBEAM

-39.4%-8.8pp

Design Therapeutics, Inc.DSGN

-37.1%+12.1pp

Prime MedicinePRME

-192.4%+94.5pp

Iovance Biotherapeutics, Inc.IOVA

-46.7%-10.7pp

FAQ

What is Intellia Therapeutics's return on invested capital?

Intellia Therapeutics (NTLA) reported return on invested capital of -62.8% in Q1 2026.

How has Intellia Therapeutics's return on invested capital changed year-over-year?

Intellia Therapeutics's return on invested capital decreased by 1.5% year-over-year, from -61.9% to -62.8%.

What is the long-term trend for Intellia Therapeutics's return on invested capital?

Over 5 years (2020 to 2025), Intellia Therapeutics's return on invested capital has grown at a 6.5% compound annual growth rate (CAGR), from -42.9% to -58.7%.

What does return on invested capital mean?

Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.